StockSelector.com
  Research, Select, & Monitor Sunday, August 18, 2019 11:57:51 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
ImmunoGen, Inc.$2.83$.082.91%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

ImmunoGen, Inc. has an overall rank of 6306 out of 7126 stocks based on 8 positive rankings and 10 negative rankings.

Positive Rankings
10 Day Gain
ImmunoGen rank is 110
Beat Whisper
According to EarningsWhispers.com, ImmunoGen beat the Earnings Whisper number when it last reported earnings. Statistics show that companies that have beat the Earnings Whisper number outperform the market in the short-term.
Target Prices
The average analysts' target price is $5.00 for ImmunoGen using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, ImmunoGen is ranked 152.
Low vPut/Call
ImmunoGen has a low Put/Call ratio of 0.37 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, ImmunoGen is ranked 805.
Low Put/Call
ImmunoGen has a low Put/Call ratio of 0.34 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, ImmunoGen is ranked 841.
90 Day Gain
ImmunoGen rank is 988
Up EPS Surprise
ImmunoGen beat the consensus earnings estimate when it last reported quarterly earnings.
Highest Cash Growth
ImmunoGen rank is 1718
Negative Rankings
Negative ROE
ImmunoGen rank is 22
Debt-to-Equity
ImmunoGen rank is 70
Negative Revenue Estimate
ImmunoGen rank is 83
Price-to-Book
ImmunoGen rank is 96
Negative Net Margin
ImmunoGen rank is 301
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, ImmunoGen is ranked 333.
Negative ROA
ImmunoGen rank is 475
Overbought Stochastics
ImmunoGen rank is 482
Price-to-Sales
ImmunoGen rank is 583
Negative Revenue Growth
ImmunoGen rank is 889







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.